Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT03058029
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Gelesis, Inc.
- Registry
-
NCT03058029
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Czechia, Denmark, Hungary, Italy, Poland, United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT03058029. Randomized; triple masking; primary purpose treatment. Start 2017-02-22 (actual); primary completion 2021-01-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes
- Acronym
- LIGHT-UP
- Condition
- Overweight
- Condition
- Diabetes
- Condition
- PreDiabetes
- Condition
- Obesity
- Intervention (Device)
- Gelesis200
- Intervention (Device)
- Placebo
- Lead sponsor
- Gelesis, Inc.
Record details
- Record id
cardio:ct-nct03058029- Content hash
d348528e774d5e757fee44dbd6aa2af078d9b41d180ea90e70b254c89fd262a6